DIFFERENCES IN THE INHIBITORY EFFECT OF CIMETIDINE ON DESIPRAMINE METABOLISM BETWEEN RAPID AND SLOW DEBRISOQUIN HYDROXYLATORS

被引:39
作者
STEINER, E [1 ]
SPINA, E [1 ]
机构
[1] HUDDINGE UNIV HOSP, METAB UNIT, S-14186 HUDDINGE, SWEDEN
关键词
D O I
10.1038/clpt.1987.147
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:278 / 282
页数:5
相关论文
共 31 条
[21]   POLYMORPHIC HYDROXYLATION OF DEBRISOQUINE IN MAN [J].
MAHGOUB, A ;
IDLE, JR ;
DRING, LG ;
LANCASTER, R ;
SMITH, RL .
LANCET, 1977, 2 (8038) :584-586
[22]   AMITRIPTYLINE METABOLISM - ASSOCIATION WITH DEBRISOQUIN HYDROXYLATION IN NONSMOKERS [J].
MELLSTROM, B ;
SAWE, J ;
BERTILSSON, L ;
SJOQVIST, F .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1986, 39 (04) :369-371
[23]   E-10-HYDROXYLATION AND Z-10-HYDROXYLATION OF NORTRIPTYLINE - RELATIONSHIP TO POLYMORPHIC DEBRISOQUINE HYDROXYLATION [J].
MELLSTROM, B ;
BERTILSSON, L ;
SAWE, J ;
SCHULZ, HU ;
SJOQVIST, F .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1981, 30 (02) :189-193
[24]   SERUM HALOPERIDOL CONCENTRATIONS AND CLINICAL-RESPONSE IN ACUTE-PSYCHOSIS [J].
MILLER, DD ;
HERSHEY, LA ;
DUFFY, JP .
DRUG INTELLIGENCE & CLINICAL PHARMACY, 1983, 17 (06) :445-445
[25]   PLASMA-CONCENTRATIONS OF NORTRIPTYLINE AND ITS 10-HYDOXY METABOLITE IN DEPRESSED-PATIENTS RELATIONSHIP TO THE DEBRISOQUINE HYDROXYLATION METABOLIC RATIO [J].
NORDIN, C ;
SIWERS, B ;
BENITEZ, J ;
BERTILSSON, L .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1985, 19 (06) :832-835
[26]  
POTTER WZ, 1981, HDB BIOL PSYCHIATR 6, P71
[27]   PHENOTYPIC CONSISTENCY IN HYDROXYLATION OF DESMETHYLIMIPRAMINE AND DEBRISOQUINE IN HEALTHY-SUBJECTS AND IN HUMAN-LIVER MICROSOMES [J].
SPINA, E ;
BIRGERSSON, C ;
VONBAHR, C ;
ERICSSON, O ;
MELLSTROM, B ;
STEINER, E ;
SJOQVIST, F .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1984, 36 (05) :677-682
[28]   DIFFERENTIAL-EFFECTS OF CIMETIDINE AND RANITIDINE ON IMIPRAMINE DEMETHYLATION AND DESMETHYLIMIPRAMINE HYDROXYLATION BY HUMAN-LIVER MICROSOMES [J].
SPINA, E ;
KOIKE, Y .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1986, 30 (02) :239-242
[29]   HYDROXYLATION OF DESMETHYLIMIPRAMINE - DEPENDENCE ON THE DEBRISOQUIN HYDROXYLATION PHENOTYPE [J].
SPINA, E ;
STEINER, E ;
ERICSSON, O ;
SJOQVIST, F .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1987, 41 (03) :314-319
[30]   A FAMILY STUDY OF GENETIC AND ENVIRONMENTAL-FACTORS DETERMINING POLYMORPHIC HYDROXYLATION OF DEBRISOQUIN [J].
STEINER, E ;
ISELIUS, L ;
ALVAN, G ;
LINDSTEN, J ;
SJOQVIST, F .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1985, 38 (04) :394-401